Catastrophic antiphospholipid syndrome: current aspects of pathogenesis, diagnosis and treatment

etiology, significance, diagnosis and treatment of bruxiam

چکیده ندارد.

Current management of catastrophic antiphospholipid syndrome

The catastrophic variant of the antiphospholipid syndrome (APS) is the most severe form and is characterized by clinical evidence of multiple organ involvement developing over a short period of time, histopathological evidence of small vessel occlusions and laboratory confirmation of antiphospholipid antibodies (aPL) as assessed in 2003 in the international consensus statement on the classifica...

Antiphospholipid syndrome in children: review of pathogenesis, diagnosis and treatment

Clinical features and pathogenesis of catastrophic antiphospholipid syndrome.

The concept of antiphospholipid syndrome (APS) has been established (1). It is well-known that one of the clinical features in APSis arterial or venous thrombosis, and that the specificity of so-called antiphospholipid antibodies have diversity against their epitopes, as so-called antiphospholipid antibodies react to phospholipids as well as plasma proteins such as p2-glycoprotein I and prothro...

[Catastrophic antiphospholipid syndrome: CAPS].

Antiphospholipid syndrome (APS) is well known as an autoimmune thrombotic syndrome with recurrent thromboses. In APS, thromboses occurs both artery and vein, and from large to micro vessels. In contrast, so called catastrophic antiphospholipid syndrome, CAPS, develops multiple thromboses at microvessels mainly within a few weeks and induces to poor prognosis. CAPS often occurs in patients with ...